ArticleInternational urology and nephrology2022

Risks of metabolic diseases and androgen deprivation therapy for prostate cancer in a Chinese population: a prospective multi-centre cohort study.

Chris Wong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.